Characterizing brain oxygen metabolism in patients with multiple sclerosis with T2-relaxation-under-spin-tagging MRI

Journal of Cerebral Blood Flow and Metabolism

Volumn 32, Issue 3, 2012, Pages 403-412

  Ge, Yulin ^a   Zhang, Zhongwei ^a   Lu, Hanzhang ^b   Tang, Lin ^a   Jaggi, Hina ^a   Herbert, Joseph ^a   Babb, James S ^a   Rusinek, Henry ^a   Grossman, Robert I ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

MRI; multiple sclerosis; neurodegeneration; nitric oxide; oxygen metabolism

Indexed keywords

BETA INTERFERON; GLATIRAMER; NATALIZUMAB; OXYGEN;

ADULT; ARTICLE; BRAIN ATROPHY; BRAIN BLOOD FLOW; BRAIN METABOLISM; BRAIN OXYGEN CONSUMPTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEGENERATIVE DISEASE; DISEASE SEVERITY; DRUG DOSE REGIMEN; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; IMAGE ANALYSIS; MALE; MULTIPLE SCLEROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OXYGEN SATURATION; PRIORITY JOURNAL;

ADULT; BRAIN; CASE-CONTROL STUDIES; CEREBROVASCULAR CIRCULATION; DATA INTERPRETATION, STATISTICAL; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; OXYGEN; OXYGEN CONSUMPTION; YOUNG ADULT;

EID: 84862776614     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2011.191     Document Type: Article

References (40)

1. Aboul-Enein F, Lassmann H (2005) Mitochondrial damage and histotoxic hypoxia: a pathway of tissue injury in inflammatory brain disease? Acta Neuropathol 109:49-55
2. Acar G, Idiman F, Idiman E, Kirkali G, Cakmakci H, Ozakbas S (2003) Nitric oxide as an activity marker in multiple sclerosis. J Neurol 250:588-92
3. Ashburner J, Friston KJ (2000) Voxel-based morphometry-the methods. Neuroimage 11:805-21
4. Barth M, Moser E. (1997) Proton NMR relaxation times of human blood samples at 1.5 T and implications for functional MRI. Cell Mol Biol (Noisy-le-grand) 43:783-91
5. Beal MF (1992) Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann Neurol 31:119-30
6. Broom KA, Anthony DC, Blamire AM, Waters S, Styles P, Perry VH, Sibson NR (2005) MRI reveals that early changes in cerebral blood volume precede blood-brain barrier breakdown and overt pathology in MS-like lesions in rat brain. J Cereb Blood Flow Metab 25: 204-16
7. Brown GC, Borutaite V (2002) Nitric oxide inhibition of mitochondrial respiration and its role in cell death. Free Radic Biol Med 33:1440-50
8. Bryant RG, Marill K, Blackmore C, Francis C (1990) Magnetic relaxation in blood and blood clots. Magn Reson Med 13:133-44
9. Buxton RB (2010) Interpreting oxygenation-based neuroimaging signals: the importance and the challenge of understanding brain oxygen metabolism. Front Neuroenergetics 2:8
10. Chiarelli PA, Bulte DP, Piechnik S, Jezzard P (2007) Sources of systematic bias in hypercapnia-calibrated functional MRI estimation of oxygen metabolism. Neuroimage 34:35-43
11. De Santi S, de Leon MJ, Rusinek H, Convit A, Tarshish CY, Roche A, Tsui WH, Kandil E, Boppana M, Daisley K, Wang GJ, Schlyer D, Fowler J (2001) Hippocampal formation glucose metabolism and volume losses in MCI and AD. Neurobiol Aging 22:529-39
12. Encinas JM, Manganas L, Enikolopov G (2005) Nitric oxide and multiple sclerosis. Curr Neurol Neurosci Rep 5: 232-8
13. Ge Y, Law M, Johnson G, Herbert J, Babb JS, Mannon LJ, Grossman RI (2005) Dynamic susceptibility contrast perfusion MR imaging of multiple sclerosis lesions: characterizing hemodynamic impairment and inflammatory activity. AJNR Am J Neuroradiol 26:1539-47
14. Ge Y, Zohrabian VM, Osa EO, Xu J, Jaggi H, Herbert J, Haacke EM, Grossman RI (2009) Diminished visibility of cerebral venous vasculature in multiple sclerosis by susceptibility-weighted imaging at 3.0 Tesla. J Magn Reson Imaging 29:1190-4
15. Golay X, Silvennoinen MJ, Zhou J, Clingman CS, Kauppinen RA, Pekar JJ, van Zij PC (2001) Measurement of tissue oxygen extraction ratios from venous blood T(2): increased precision and validation of principle. Magn Reson Med 46:282-91
16. Gomori JM, Grossman RI, Yu-Ip C, Asakura T (1987) NMR relaxation times of blood: dependence on field strength, oxidation state, and cell integrity. J Comput Assist Tomogr 11:684-90
17. Guyton AC, Hall JE (2005) Respiration. In: Testbook of Medical Physiology (Guyton AC, Hall JE, eds), Saunders: Elsevier
18. Inglese M, Park SJ, Johnson G, Babb JS, Miles L, Jaggi H, Herbert J, Grossman RI (2007) Deep gray matter perfusion in multiple sclerosis: dynamic susceptibility contrast perfusion magnetic resonance imaging at 3 T. Arch Neurol 64:196-202
19. Law M, Saindane AM, Ge Y, Babb JS, Johnson G, Mannon LJ, Herbert J, Grossman RI (2004) Microvascular abnormality in relapsing-remitting multiple sclerosis: perfusion MR imaging findings in normal-appearing white matter. Radiology 231:645-52
20. Leontiev O, Buxton RB (2007) Reproducibility of BOLD, perfusion, and CMRO2 measurements with calibrated-BOLD fMRI. Neuroimage 35:175-84
21. Lisak RP (2007) Neurodegeneration in multiple sclerosis: defining the problem. Neurology 68:S5-12; discussion S43-S54
22. Lu H, Clingman C, Golay X, van Zijl PC (2004) Determining the longitudinal relaxation time (T1) of blood at 3.0 Tesla. Magn Reson Med 52:679-82
23. Lu H, Ge Y (2008) Quantitative evaluation of oxygenation in venous vessels using T2-relaxation-under-spin-tagging MRI. Magn Reson Med 60:357-63
24. Lu H, Xu F, Grgac K, Liu P, Qin Q, van Zijl P (2011) Calibration and validation of TRUST MRI for the estimation of cerebral blood oxygenation. Magn Reson Med 67:42-9
25. Lu H, Zhao C, Ge Y, Lewis-Amezcua K (2008) Baseline blood oxygenation modulates response amplitude: physiologic basis for intersubject variations in functional MRI signals. Magn Reson Med 60:364-72
26. Moncada S, Bolanos JP (2006) Nitric oxide, cell bioenergetics and neurodegeneration. J Neurochem 97: 1676-89
27. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Johnson KP, Sibley WA, Silberberg DH, Tourtellotte WW (1983) New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13:227-31
28. Prinster A, Quarantelli M, Lanzillo R, Orefice G, Vacca G, Carotenuto B, Alfano B, Brunetti A, Morra VB, Salvatore M (2010) A voxel-based morphometry study of disease severity correlates in relapsing-remitting multiple sclerosis. Mult Scler 16:45-54
29. Rejdak K, Eikelenboom MJ, Petzold A, Thompson EJ, Stelmasiak Z, Lazeron RH, Barkhof F, Polman CH, Uitdehaag BM, Giovannoni G (2004) CSF nitric oxide metabolites are associated with activity and progression of multiple sclerosis. Neurology 63:1439-45
30. Smith KJ, Lassmann H (2002) The role of nitric oxide in multiple sclerosis. Lancet Neurol 1:232-41
31. Su KG, Banker G, Bourdette D, Forte M (2009) Axonal degeneration in multiple sclerosis: the mitochondrial hypothesis. Curr Neurol Neurosci Rep 9:411-7
32. Sun X, Tanaka M, Kondo S, Okamoto K, Hirai S (1998) Clinical significance of reduced cerebral metabolism in multiple sclerosis: a combined PET and MRI study. Ann Nucl Med 12:89-94
33. Thulborn KR, Waterton JC, Matthews PM, Radda GK (1982) Oxygenation dependence of the transverse relaxation time of water protons in whole blood at high field. Biochim Biophys Acta 714:265-70
34. Trapp BD, Ransohoff R, Rudick R (1999) Axonal pathology in multiple sclerosis: relationship to neurologic disability. Curr Opin Neurol 12:295-302
35. Trapp BD, Stys PK (2009) Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis. Lancet Neurol 8:280-91
36. Wong EC, Buxton RB, Frank LR (1997) Implementation of quantitative perfusion imaging techniques for functional brain mapping using pulsed arterial spin labeling. NMR Biomed 10:237-49
37. Wright GA, Hu BS, Macovski A (1991) 1991 I.I. Rabi Award. Estimating oxygen saturation of blood in vivo with MR imaging at 1.5 T. J Magn Reson Imaging 1:275-83
38. Wuerfel J, Bellmann-Strobl J, Brunecker P, Aktas O, McFarland H, Villringer A, Zipp F (2004) Changes in cerebral perfusion precede plaque formation in multiple sclerosis: a longitudinal perfusion MRI study. Brain 127:111-9
39. Xu F, Ge Y, Lu H (2009) Noninvasive quantification of whole-brain cerebral metabolic rate of oxygen (CMRO2) by MRI. Magn Reson Med 62:141-8
40. Zhao JM, Clingman CS, Narvainen MJ, Kauppinen RA, van Zijl PC (2007) Oxygenation and hematocrit dependence of transverse relaxation rates of blood at 3T. Magn Reson Med 58:592-7